Richard Kivel

Directeur Général chez Rhapsody Biologics, Inc.

Profil

Richard Paul Kivel is the founder of Rhapsody Biologics, Inc. since 2009, holding the title of Chairman & Chief Executive Officer.
Current jobs include Managing Director at GrayBella Capital LLC and Trustee at Bankinter Foundation of Innovation since 2009.
Former jobs include Chief Executive Officer at MolecularWare, Inc. from 2001 to 2004, Chief Executive Officer at TheraGenetics Ltd. from 2006 to 2009, Executive Chairman at ViS Research, Inc. from 2013 to 2015, Chairman & President at MIT Enterprise Forum, Inc. from 2006 to 2011, Chairman at BC Platforms AG from 2018 to 2023, Vice President & Sales Director at Interliant, Inc., Independent Director at Rexahn Pharmaceuticals, Inc. from 2010 to 2013, Director at AutoLotto, Inc., Director at MIT Alumni Association, Director at Lottery.com, Inc. in 2022, Chief Operating Officer at Ixcela, Inc. from 2014 to 2016, Member-Alumni Association Board at Massachusetts Institute of Technology, and Vice President-Sales at Net Daemons Associates, Inc. Education includes an undergraduate degree from American International College and a graduate degree from Boston College.

Postes actifs de Richard Kivel

Sociétés	Poste	Début
Rhapsody Biologics, Inc.	Directeur Général	01/10/2009
Bankinter Foundation of Innovation	Directeur/Membre du Conseil	-
GrayBella Capital LLC	Private Equity Investor	-

Anciens postes connus de Richard Kivel

Sociétés	Poste	Fin
BC Platforms AG	Président	01/04/2023
LOTTERY.COM	Président	29/10/2022
Ixcela, Inc.	Directeur des opérations	01/01/2016
ViS Research, Inc.	Président	01/01/2015
REXAHN PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	10/06/2013